Quantbot Technologies’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-88
Closed -$2.79K 2141
2025
Q4
$2.79K Buy
+88
New +$2.65K ﹤0.01% 1634
2023
Q1
Sell
-3,291
Closed -$30.4K 2038
2022
Q4
$30.4K Buy
+3,291
New +$34.2K ﹤0.01% 1386
2022
Q2
Sell
-4,300
Closed -$90K 2113
2022
Q1
$90K Buy
4,300
+2,900
+207% +$58.1K 0.01% 1071
2021
Q4
$33K Buy
1,400
+200
+17% +$4.77K ﹤0.01% 1137
2021
Q3
$30K Buy
1,200
+1,000
+500% +$27.9K ﹤0.01% 1201
2021
Q2
$6K Hold
200
﹤0.01% 1349
2021
Q1
$7K Hold
200
﹤0.01% 1278
2020
Q4
$12K Hold
200
﹤0.01% 1084
2020
Q3
$6K Buy
+200
New +$5.71K ﹤0.01% 1171

Other funds holding STOK

Quantbot Technologies's STOK Position: Q1 2026 in Review

Quantbot Technologies sold out of Stoke Therapeutics (STOK) in Q1 2026, closing a stake of 88 shares — an estimated $2.79K sold.

Quantbot Technologies first reported a position in STOK in Q3 2020 and held it in 9 quarters. The position peaked at $90K in Q1 2022. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Quantbot Technologies reported no remaining Stoke Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 88 Stoke Therapeutics shares in Q1 2026, an estimated $2.79K.
  • Quantbot Technologies first reported a position in Stoke Therapeutics in Q3 2020 and held it in 9 quarters.
  • Quantbot Technologies's Stoke Therapeutics position peaked at $90K in Q1 2022.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.